Glucosamine-Induced Inhibition of Liver Glucokinase Impairs the Ability of Hyperglycemia to Suppress Endogenous Glucose Production

@article{Barzilai1996GlucosamineInducedIO,
  title={Glucosamine-Induced Inhibition of Liver Glucokinase Impairs the Ability of Hyperglycemia to Suppress Endogenous Glucose Production},
  author={Nir Barzilai and Meredith Hawkins and I v Angelov and Meizhu Hu and Luciano Rossetti},
  journal={Diabetes},
  year={1996},
  volume={45},
  pages={1329 - 1335}
}
Although the kinetic characteristics of hepatic glucokinase (GK) suggest its potential role as the hepatic “glucose sensor,” its impact on the regulation of in vivo hepatic glucose production (HGP) is still controversial. Since decreased GK activity has been linked to experimental and human diabetes, we examined whether a moderate and transient inhibition of GK activity diminishes the ability of hyperglycemia to suppress HGP. We first determined the concentration of the competitive inhibitor… Expand
Glucose Toxicity Is Responsible for the Development of Impaired Regulation of Endogenous Glucose Production and Hepatic Glucokinase in Zucker Diabetic Fatty Rats
TLDR
Glucotoxicity may result in the blunted response of hepatic glucose flux to elevated plasma glucose and/or insulin associated with impaired regulation of GK by GKRP in ZDF rats. Expand
Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat.
TLDR
Investigation of intrahepatic mechanisms by which insulin may inhibit hepatic glucose production in the rat found a sustained glucose-phosphorylation flux might be a crucial determinant in the inhibition of G-6-Pase and of HGP. Expand
Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rat.
TLDR
Investigation of intrahepatic mechanisms by which insulin may inhibit hepatic glucose production in the rat found a sustained glucose-phosphorylation flux might be a crucial determinant in the inhibition of G-6-Pase and of HGP. Expand
Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele.
TLDR
It is concluded that, although impaired glucose-induced insulin secretion is common to both models of decreased pancreatic GK activity, the marked impairment in the ability of hyperglycemia to inhibit HGP is due to the specific decrease in hepatic Gk activity. Expand
Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal
TLDR
It is shown that increased GlcN availability also impairs the effects of IGF-1 on glucose uptake, glycolysis, and glycogen synthesis, and IGF- 1 was unable to overcome Glcn-induced insulin resistance. Expand
A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes.
TLDR
The decreased glucose effectiveness to suppress EGP and stimulate hepatic glucose uptake may result from failure of the sugar to activate GK by stimulating the translocation of the enzyme. Expand
Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
TLDR
The administration of small amounts of fructose to type 2 diabetic subjects partially corrected the regulation of GP by hyperglycemia per se, yet did not affect this regulation in the nondiabetic subjects, which suggests that the liver's inability to respond to hyper glycemia in type 2 diabetes contributes substantially to the increased GP in these individuals. Expand
Effects of glucosamine infusion on insulin secretion and insulin action in humans.
TLDR
In humans, acute GlcN infusion recapitulates some metabolic features of human diabetes, and it remains to be determined whether acceleration of the hexosamine pathway can cause insulin resistance at euglycemia in humans. Expand
High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetes.
TLDR
The joint administration of supranutritional doses of biotin and chromium picolinate is likely to combat insulin resistance, improve beta-cell function, enhance postprandial glucose uptake by both liver and skeletal muscle, and inhibit excessive hepatic glucose production. Expand
Restoration of Hepatic Glucokinase Expression Corrects Hepatic Glucose Flux and Normalizes Plasma Glucose in Zucker Diabetic Fatty Rats
TLDR
Alteration of hepatic GK activity in ZDF rats has profound effects on plasma glucose and hepatic glucose flux and normalized plasma glucose levels and endogenous glucose production. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 38 REFERENCES
Glucosamine Inhibits Glucokinase In Vitro and Produces a Glucose-Specific Impairment of In Vivo Insulin Secretion in Rats
TLDR
It is concluded that glucosamine, probably via a reduction of glucokinase activity, impairs insulin secretion in a manner comparable to that seen in NIDDM. Expand
Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin.
TLDR
The data suggest that GK and Glc-6-Pase are important determinants of fasting HGP in diabetes, however, acute changes in Glc/GK activities can account for only a small portion of the in vivo inhibition of hepatic glucose flux by insulin, suggesting additional mechanisms for the short-term regulation of HGP. Expand
Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.
TLDR
Results indicate that in the diabetic state, under hyperinsulinemic conditions, hyperglycemia normally stimulates liver glycogen synthesis through a marked increase in the indirect pathway, which in turn may compensate for the reduction in the direct pathway. Expand
Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes.
TLDR
Hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase under similar hyperglycemic hypoinsulinemic conditions. Expand
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
TLDR
In normal humans there is an autoregulatory process independent of changes in plasma glucose and glucoregulation hormone concentrations which prevents a substrate-induced increase in gluconeogenesis from increasing overall hepatic glucose output; since this process cannot be explained on the basis of inhibition of gluc oneogenesis from other substrates, it probably involves diminution of glycogenolysis. Expand
In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats.
TLDR
The lack of additive effects of GlcN and chronic hyperglycemia (experimental diabetes) provides support for the hypothesis that increased flux through the Glcn pathway in skeletal muscle may play an important role in glucose-induced insulin resistance in vivo. Expand
Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
TLDR
It is concluded that in the presence of basal insulin levels hyperglycemia inhibits glucose output independent of a rise in insulin or a fall in anti-insulin hormones. Expand
Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
The first aim of this study was to determine whether the plasma glucose level can regulate hepatic glucose balance in vivo independent of its effects on insulin and glucagon secretion. To accomplishExpand
Regulation of glucokinase in liver.
  • S. Weinhouse
  • Biology, Medicine
  • Current topics in cellular regulation
  • 1976
TLDR
It can be concluded that glucokinase is not involved in the physiological utilization of sugars other than glucose, it is not likely to be affected by physiological concentration variations of ATP, adenosine diphosphate (ADP), or glucose 6-phosphate; and it is free of allosteric effects. Expand
Regulation of Glycogen Synthase and Protein Phosphatase-1 by Hexosamines
TLDR
Both basal and insulin-stimulable GS and PP1 activity are downregulated by high glucose in fibroblasts and this regulation is mediated by products of the hexosamine biosynthesis pathway. Expand
...
1
2
3
4
...